The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | Common | 00032Q104 | 6,667,601 | 2,849,402 | SH | SOLE | 2,849,402 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | Common | 02043Q107 | 44,835,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | Common | 02083G100 | 228,921,000 | 5,775,000 | SH | SOLE | 5,775,000 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | Common | 03152W109 | 322,772,000 | 27,400,000 | SH | SOLE | 27,400,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | Common | 03753U106 | 653,111,105 | 11,111,111 | SH | SOLE | 11,111,111 | 0 | 0 | ||
ARGENX SE | Sponsored ADR | 04016X101 | 487,609,227 | 1,238,467 | SH | SOLE | 1,238,467 | 0 | 0 | ||
ARROWHEAD PHARMACEUTICALS INC | Common | 04280A100 | 244,688,873 | 8,555,555 | SH | SOLE | 8,555,555 | 0 | 0 | ||
ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 599,640,899 | 3,966,666 | SH | SOLE | 3,966,666 | 0 | 0 | ||
AUTOLUS THERAPEUTICS PLC | Sponsored ADR | 05280R100 | 78,765,426 | 12,345,678 | SH | SOLE | 12,345,678 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | Common | 05370A108 | 148,654,000 | 5,825,000 | SH | SOLE | 5,825,000 | 0 | 0 | ||
ADVERUM BIOTECHNOLOGIES INC | Common | 00773U207 | 5,891,657 | 416,666 | SH | SOLE | 416,666 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | Common | 09058V103 | 66,294,000 | 13,050,000 | SH | SOLE | 13,050,000 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 381,239,100 | 4,365,000 | SH | SOLE | 4,365,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG | Common | 15678U128 | 319,373,310 | 7,555,555 | SH | SOLE | 7,555,555 | 0 | 0 | ||
CG ONCOLOGY INC | Common | 156944100 | 30,730,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
CRISPR THERAPEUTICS AG | Common | H17182108 | 28,598,573 | 419,580 | SH | SOLE | 419,580 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | Common | 46116X101 | 171,270,000 | 2,475,000 | SH | SOLE | 2,475,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 173,394,000 | 11,700,000 | SH | SOLE | 11,700,000 | 0 | 0 | ||
KRYSTAL BIOTECH INC | Common | 501147102 | 454,709,901 | 2,555,555 | SH | SOLE | 2,555,555 | 0 | 0 | ||
KURA ONCOLOGY INC | Common | 50127T109 | 82,120,500 | 3,850,000 | SH | SOLE | 3,850,000 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | Common | 501575104 | 156,333,298 | 3,888,888 | SH | SOLE | 3,888,888 | 0 | 0 | ||
KYVERNA THERAPEUTICS INC | Common | 501976104 | 11,799,000 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | ||
MACROGENICS INC | Common | 556099109 | 90,528,000 | 6,150,000 | SH | SOLE | 6,150,000 | 0 | 0 | ||
MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 519,244,326 | 1,944,444 | SH | SOLE | 1,944,444 | 0 | 0 | ||
MANNKIND CORP | Common | 56400P706 | 40,770,000 | 9,000,000 | SH | SOLE | 9,000,000 | 0 | 0 | ||
MARINUS PHARMACEUTICALS INC | Common | 56854Q200 | 37,431,087 | 4,140,607 | SH | SOLE | 4,140,607 | 0 | 0 | ||
MERUS N V | Common | N5749R100 | 40,026,627 | 888,888 | SH | SOLE | 888,888 | 0 | 0 | ||
MONTE ROSA THERAPEUTICS INC | Common | 61225M102 | 31,971,750 | 4,535,000 | SH | SOLE | 4,535,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 129,593,400 | 2,580,000 | SH | SOLE | 2,580,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | Common | 67576A100 | 65,055,318 | 7,148,936 | SH | SOLE | 7,148,936 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | Common | 77313F106 | 33,968,646 | 1,260,900 | SH | SOLE | 1,260,900 | 0 | 0 | ||
ROIVANT SCIENCES LTD | Common | G76279101 | 49,023,247 | 4,651,162 | SH | SOLE | 4,651,162 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | Common | 803607100 | 562,431,720 | 4,344,444 | SH | SOLE | 4,344,444 | 0 | 0 | ||
SOLENO THERAPEUTICS INC | Common | 834203309 | 69,550,000 | 1,625,000 | SH | SOLE | 1,625,000 | 0 | 0 | ||
SPDR SERIES TRUST - S&P BIOTECH | ETF | 78464A870 | 408,027,000 | 4,300,000 | SH | SOLE | 4,300,000 | 0 | 0 | ||
SPYRE THERAPEUTICS INC | Common | 00773J202 | 69,758,504 | 1,839,138 | SH | SOLE | 1,839,138 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | Common | 87164F105 | 100,488,884 | 4,222,222 | SH | SOLE | 4,222,222 | 0 | 0 | ||
TAYSHA GENE THERAPIES INC | Common | 877619106 | 53,525,500 | 18,650,000 | SH | SOLE | 18,650,000 | 0 | 0 | ||
TOURMALINE BIO INC | Common | 89157D105 | 50,888,884 | 2,222,222 | SH | SOLE | 2,222,222 | 0 | 0 | ||
ULTRAGENYX PHARMACEUTICAL INC | Common | 90400D108 | 38,752,700 | 830,000 | SH | SOLE | 830,000 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | Common | 91307C102 | 656,743,751 | 2,858,888 | SH | SOLE | 2,858,888 | 0 | 0 | ||
VAXCYTE INC | Common | 92243G108 | 39,278,250 | 575,000 | SH | SOLE | 575,000 | 0 | 0 | ||
VERA THERAPEUTICS INC | Common | 92337R101 | 227,026,800 | 5,265,000 | SH | SOLE | 5,265,000 | 0 | 0 | ||
VERRICA PHARMACEUTICALS INC | Common | 92511W108 | 23,679,994 | 3,999,999 | SH | SOLE | 3,999,999 | 0 | 0 | ||
VIKING THERAPEUTICS INC | Common | 92686J106 | 294,380,000 | 3,590,000 | SH | SOLE | 3,590,000 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | Common | 98420N105 | 243,949,971 | 5,666,666 | SH | SOLE | 5,666,666 | 0 | 0 |